
240: #JPM23, the future of Alzheimer's, & rising Covid variants
The Readout Loud
00:00
ESI vs Biogen - What's the Difference?
ESI has been in charge of this one versus biogen being in charge of the last one. The FDA is very fortunate that ASI was able to conduct that confirmatory study, you know, it's a really weird situation, right? That what we're going to get probably Friday or whenever we'll get accelerated approval based on amyloid lowering.
Transcript
Play full episode